RS504393

RS504393 is an antagonist of CCR used in studies of Immune Signaling and GPCR Signaling. In practice, this places the compound in experiments that measure cytokine-mediated signaling and inflammatory effector responses and receptor-driven second-messenger signaling and desensitization dynamics in immunology, inflammation, and infectious disease models.

By blocking CCR, RS504393 can be used to examine cytokine-mediated signaling and inflammatory effector responses and receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In immunology, inflammation, and infectious disease models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CCR
• Pathway perturbation studies connected to Immune Signaling and GPCR Signaling
• Receptor-blockade and ligand-competition studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, RS504393 is appropriate when a defined chemical perturbant is needed to connect CCR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in immunology, inflammation, and infectious disease models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.